This dysfunction was also associated with certain biomarkers, like the apolipoprotein E (APOE) ε4 allele, tau protein, and amyloid-β deposits, which were implicated in adverse health outcomes such as cardiovascular diseases, and Alzheimer’s disease [38,39]. The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.